Concepedia

Author

Yan Wang

Chinese PLA General HospitalORCID

Also Known As

Peng Xin, QingQing Qi, Wang, Yan, Y. Wang, Yan Wang, Yang Wang

68

Publications

249

Citations

8

H-Index

26

Concepts

All Affiliations

Chinese PLA General HospitalFudan UniversitySun Yat-sen University
YW

About

Yan Wang is an author at Chinese PLA General Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

47

2

Health Sciences

1

1

21

3

Cell Biology

1

1

10

4

Molecular Medicine

1

1

10

5

Neurology

1

1

21

Yan Wang

×

8

Publications

174

Citations

8

H-Index

YearCitations

PRSS contributes to cetuximab resistance in colorectal cancer

Zhao-Li Tan, Lihua Gao, Yan Wang,

Science Advances

2020

37

Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment

Ranran Chen, Yuanjian Huang, Lu Wang,

Biomaterials Science

2021

34

Preliminary Study on Cervical Spinal Cord in Patients with Amyotrophic Lateral Sclerosis Using MR Diffusion Tensor Imaging

Yan Wang, Li Liu, Lin Ma,

Academic Radiology

2014

21

Radiomics Analysis of DTI Data to Assess Vision Outcome After Intravenous Methylprednisolone Therapy in Neuromyelitis Optic Neuritis

Yuan Tian, Zhenyu Liu, Zhenchao Tang,

Journal of Magnetic Resonance Imaging

2018

20

Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study

Xiaojing Xu, Luoyan Ai, Keshu Hu,

Nature Communications

2024

19

Combined transcatheter arterial chemoembolization and radiofrequency ablation in single‐session for solitary hepatocellular carcinoma larger than 7 cm

Jieyu Yan, Jinlong Zhang, M Q Wang,

Asia-Pacific Journal of Clinical Oncology

2017

17

Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study

Ting Deng, Le Zhang, Xiao-jian Liu,

Medical Oncology

2013

16

Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib

Sebastian Gamba, Peter Čamaj, Volker Heinemann,

Anti-Cancer Drugs

2014

10

Page 1